Patricia L. Kropf, MD¹, Philip A. Pancari, MD², Henry Fung^3*, Hagop M. Kantarjian, MD⁴, Lianchun Xiao^5*, Huang Xuelin^6* and Jean-Pierre Issa, MD^7*

¹Fox Chase Cancer Center, Philadelphia, PA
²Fox Chase Cancer Center, Philadelphia
³Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵MD Anderson, Houston
⁶Biostatistics, University of Texas, The MD Anderson Cancer Center, Houston
⁷Fels Institute, Temple University, Philadelphia, PA

Farhad Ravandi, MD¹, Jorge E. Cortes, MD², Guillermo Garcia-Manero, MD³, Elihu Estey^4*, Gautam Borthakur, MD¹, Elias J Jabbour, MD¹, Stefan Faderl, MD^5*, Susan O'Brien, MD⁶, William Wierda, MD, PhD², Sherry Pierce, BSN, BA^7*, Mark Brandt, BS^2*, Steven M. Kornblau, MD¹, Tapan Kadia, MD², Naval Daver, MD¹, Courtney DiNardo, MD¹, Srdan Verstovsek, MD, PhD⁸, Alessandra Ferrajoli, MD¹, Michael Andreeff, MD, PhD⁹, Marina Konopleva, MD, PhD¹⁰, Zeev Estrov, MD¹¹, Maria Foudray^8* and Hagop M. Kantarjian, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
⁴Division of Hematology, University of Washington School of Medicine, Seattle, WA
⁵John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁶University of California - Irvine, Orange, CA
⁷Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Leukemia, University of Texas - MD Anderson Cancer Center, Houston, TX
⁹Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
¹⁰Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Yasmin H Karimi, MD^1*, Nitin Jain, MD², Margaret Green^1*, Lucy A Godley, M.D., Ph.D.¹, Howie Lawrence Weiner^1*, Gregory Malnassy^1*, Noreen Fulton^1*, Andrew Artz, MD, MS¹, Hongtao Liu, MD, PhD¹, Michael J. Thirman, MD¹, Michael Daunov^1*, Richard A. Larson, MD¹, Wendy Stock, MD¹ and Olatoyosi Odenike, MD¹

¹University of Chicago Medical Center, Chicago, IL
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Yi Luo^1*, Lung-Ji Chang, PhD^2,3*, Yongxian Hu, MD^1*, Lujia Dong^4*, Guoqing Wei^1* and He Huang, MD, PhD⁵

¹Bone Marrow Transplantation Center, the First Affiliated Hospital of Zhejiang University, Hangzhou, China
²Shenzhen Genoimmune Medical Institute (GIMI),, Shenzhen, China
³Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL
⁴America Yuva Biomed, Bejing, China
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University, School of Medicine., Hangzhou, China

Anand Jillella, MD¹, Martha Arellano, MD¹, Asad Bashey, MD, PhD², Sarah I. Vidito, DO³, Robert K. Stuart, MD⁴, Caleb Leung^5*, Kaitlin Sitchenko^1*, Manila Gaddh, MD^1*, Leonard T Heffner Jr., MD¹, Ravindra B. Kolhe, MD, PhD^6*, Jacques Galipeau, MD⁷, Amelia Langston, MD¹ and Vamsi K Kota, MD¹

¹Winship Cancer Institute of Emory University, Atlanta, GA
²The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
³Palmetto Hematology Oncology, Spartanburg, SC
⁴Hollings Cancer Center, Medical Univ. of South Carolina, Charleston, SC
⁵Chattahooche High School, Johns Creek, GA
⁶Georgia Regents University, Augusta, GA
⁷Hematology and Medical Oncology, Pediatrics, Emory University, Atlanta, GA

Christian Jakob, MD¹, Benjamin Gunther, MD^1*, Katharina Dittberner, MD^1*, Leonard Boger, MD^1*, Philipp Bleienheuft, MD^1*, Frank Breywisch, MD^1*, Frank Rothmann, MD^1*, Stefan Peinert, MD² and Georg Maschmeyer, MD¹

¹Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany
²Practice for Hematology and Oncology, Aurich, Germany

Varda Deutsch, PhD¹, Sigi Kay, PhD^1*, Hila Jan, MSc^2*, Ben Zion Katz, PhD^2,3* and Michal Cipok, PhD^1*

¹The Hematology Institute, Tel Aviv Medical Center, Tel Aviv, Israel
²Hematology, Tel Aviv Medical Center, Tel Aviv, Israel
³Sackler Faculty of Medicine, Tel Aviv University,, Tel Aviv, Israel

Nan Xinyu^1*, Srivastava Pallavi^1*, Mamta Puppala, MSc^2*, Sai Ravi Pingali, MD,^1*, Ibrahim Ibrahim^1*, Lawrence Rice, MD³, Alexandria T. Phan, MD⁴ and Swaminathan Padmanabhan Iyer, MD⁵

¹Houston Methodist Cancer Center, Weill Cornell Medical College, Houston
²Houston Methodist Research Institute, Weill Cornell Medical College, Houston
³Department of Medicine, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX
⁴Houston Methodist Cancer Center, Houston, TX
⁵Hematology, Early Drug Development, Houston Methodist Cancer Center/Weill Cornell Medical College, Houston, TX

Reed Friend, MD¹, Ridas Juskevicius, MD^2*, Lauren Salmon, DO¹, Hemant S. Murthy, MD^3*, James Xenakis^4*, Adam S. Asch, MD^5* and Paul Walker, MD^1*

¹Leo Jenkins Cancer Center, East Carolina University, Greenville, NC
²Department of Pathology, Brody School of Medicine at East Carolina University, Greenville, NC
³Blood and Marrow Transplant, Moffitt Cancer Center, Greenville, NC
⁴Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
⁵Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK